Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- Check7 days agoChange DetectedRevision v3.5.2 was added and revision v3.5.0 was removed from the record history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was removed.SummaryDifference0.1%

- Check42 days agoChange DetectedA new site revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.4.2 was added to the study record history. The funding-status banner and the previous revision v3.4.1 were removed.SummaryDifference0.8%

- Check78 days agoChange DetectedAdded a government funding notice about operating status and the latest revision tag (v3.4.1); removed the previous revision tag (v3.4.0).SummaryDifference0.8%

- Check85 days agoChange DetectedThe history view now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with an updated revision note (v3.4.0). The older revision note (v3.3.4) and No FEAR Act data entry are removed.SummaryDifference1%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.